Structural and functional alterations to the gut microbiome, referred to as gut dysbiosis, have
emerged as potential key mediators of neurodegeneration and Alzheimer disease (AD) …

Brain-derived neurotrophic factor (BDNF), a protein belonging to the neurotrophin family, is
known to be heavily involved in synaptic plasticity processes that support brain …

Maternal immune activation is an environmental risk factor for the development of
neuropsychiatric disorders such as anxiety and depression later in life. There is an urgent …

Aims Mild traumatic brain injury (mTBI) is an important risk factor for cognitive impairment.
Despite intense efforts to develop efficient treatments, the current therapies are not often …

Epilepsy is a chronic brain disease affecting millions of people worldwide. Anxiety-related
disorders and cognitive deficits are common in patients with epilepsy. Previous studies have …

Alzheimer's disease (AD) is associated with increased depression-related behaviours.
Previous studies have reported a greater risk of AD and depression in women. In recent …

Gestational stress can increase postpartum depression in women. To treat maternal
depression, fluoxetine (FLX) is most commonly prescribed. While FLX may be effective for …

Anxiety-related behaviors are among the most prevalent psychiatric disorders in patients
with type 2 diabetes (T2D). The protective effect of exercise on neuropsychiatric disorders …

There is a growing interest in investigating the effects of physical exercise on cognitive
performance, particularly episodic memory. Similarly, an increasing number of studies in …

Alzheimer's disease (AD) is a progressive degenerative brain disease and the primary
cause of dementia. At an early stage, AD is generally characterized by short-term memory …